HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma. (3rd August 2017)
- Record Type:
- Journal Article
- Title:
- HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma. (3rd August 2017)
- Main Title:
- HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma
- Authors:
- Xie, Shumin
Wang, Xiaoli
Ren, Hongmiao
Liu, Xiaoyu
Ren, Jihao
Liu, Wei - Abstract:
- Abstract: Conclusions: The heparin-binding epidermal growth factor-like growth factor (HB-EGF) plays an essential role in the development and invasiveness of cholesteatoma. This study may help to realize the molecular mechanisms underlying the pathogenesis of cholesteatoma and make HB-EGF a promising target for drug intervention of cholesteatoma. Objective: To detect HB-EGF expression in human surgical specimens of acquired middle ear cholesteatoma and analyze its functional role as a regulator of epithelial keratinocytes hyperproliferation. Methods: A total of 34 patients who underwent surgical treatment for middle ear cholesteatoma were recruited in the study. The mRNA and protein expression of HB-EGF in middle ear cholesteatoma tissues and normal postauricular skin tissues was investigated by real-time quantitative reverse-transcription-polymerase chain reaction (RT-qPCR), immunohistochemical staining, and western blot. The correlation between bone resorption degree and HB-EGF expression was also analyzed. Results: On average, compared with normal postauricular skin, expression of HB-EGF mRNA in the cholesteatoma epithelium was significantly elevated 2.41-fold by RT-qPCR, and HB-EGF protein significantly upregulated 2.32-fold by western blot. Positive HB-EGF immunostaining observed in the basal and suprabasal layers of cholesteatoma epithelium was significantly stronger than in normal postauricular skin. Meanwhile, an obviously positive correlation between HB-EGF proteinAbstract: Conclusions: The heparin-binding epidermal growth factor-like growth factor (HB-EGF) plays an essential role in the development and invasiveness of cholesteatoma. This study may help to realize the molecular mechanisms underlying the pathogenesis of cholesteatoma and make HB-EGF a promising target for drug intervention of cholesteatoma. Objective: To detect HB-EGF expression in human surgical specimens of acquired middle ear cholesteatoma and analyze its functional role as a regulator of epithelial keratinocytes hyperproliferation. Methods: A total of 34 patients who underwent surgical treatment for middle ear cholesteatoma were recruited in the study. The mRNA and protein expression of HB-EGF in middle ear cholesteatoma tissues and normal postauricular skin tissues was investigated by real-time quantitative reverse-transcription-polymerase chain reaction (RT-qPCR), immunohistochemical staining, and western blot. The correlation between bone resorption degree and HB-EGF expression was also analyzed. Results: On average, compared with normal postauricular skin, expression of HB-EGF mRNA in the cholesteatoma epithelium was significantly elevated 2.41-fold by RT-qPCR, and HB-EGF protein significantly upregulated 2.32-fold by western blot. Positive HB-EGF immunostaining observed in the basal and suprabasal layers of cholesteatoma epithelium was significantly stronger than in normal postauricular skin. Meanwhile, an obviously positive correlation between HB-EGF protein expression and bone resorption degree was discovered. … (more)
- Is Part Of:
- Acta oto-laryngologica. Volume 137:Number 8(2017)
- Journal:
- Acta oto-laryngologica
- Issue:
- Volume 137:Number 8(2017)
- Issue Display:
- Volume 137, Issue 8 (2017)
- Year:
- 2017
- Volume:
- 137
- Issue:
- 8
- Issue Sort Value:
- 2017-0137-0008-0000
- Page Start:
- 797
- Page End:
- 802
- Publication Date:
- 2017-08-03
- Subjects:
- Cholesteatoma -- HB-EGF -- bone resorption -- etiopathogenesis
Otolaryngology -- Periodicals
Ear -- Diseases -- Periodicals
Throat -- Diseases -- Periodicals
Otolaryngology -- Electronic Resources
Otorhinolaryngologic Diseases
617.8 - Journal URLs:
- http://www.tandfonline.com/loi/ioto20#.V6CqjFJTHcs ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/00016489.2017.1284343 ↗
- Languages:
- English
- ISSNs:
- 0001-6489
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0642.250000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 752.xml